Risk factors associated with mucositis in cancer patients receiving 5- fluorouracil

Oral Oncology

Volumn 34, Issue 6, 1998, Pages 484-490

  McCarthy, G M ^a   Awde, J D ^a   Ghandi, H ^a   Vincent, M ^a   Kocha, W I ^a  

^a NONE

Author keywords

5 Fluorouracil; Cancer chemotherapy; Neutrophils; Oral mucositis; Salivary flow; Xerostomia

Indexed keywords

FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; RISK FACTOR; SALIVATION; STATISTICAL ANALYSIS; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COHORT STUDIES; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIMPLEXVIRUS; STOMATITIS;

EID: 0031787082     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00068-2     Document Type: Article

References (66)

1. Wingo P. A., Tong T., Bolden S. Cancer statistics: 1995. CA: A Cancer Journal for Clinicians. 45:1995;8-30.
2. Pinedo H. M., Peters G. J. Fluorouracil: biochemistry and pharmacology. Journal of Clinical Oncology. 6:1988;1653-1664.
3. Diaz-Rubio E., Aranda E., Martin M., Gonzalez-Mancha R., Gonzalez-Larriba J., Barneto I. Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer. European Journal of Cancer. 26:1990;727-729.
4. Fluorouracil Injection. Compendium of Pharmaceuticals and Specialities, 1997, p. 593-594.
5. Koenig H., Patel A. Biochemical basis for fluorouracil neurotoxicity: the role of Krebs Cycle inhibition by fluoroacetate. Archives of Neurology. 23:1970;155-160.
6. Peterson D. E., Sonis S. T. Oral complications of cancer chemotherapy: present status and future studies. Cancer Treatment Reports. 66:1982;1251-1256.
7. Carnel S. B., Blakeslee D. B., Oswald S. G., Barmes M. Treatment of radiation- and chemotherapy-induced stomatitis. Otolaryngology Head and Neck Surgery. 102:1990;326-330.
8. Cascinu S., Fedeli A., Fedeli S. L., Catalano G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Oral Oncology: European Journal of Cancer. 30B:1994;234-236.
9. Miaskowski C. Management of mucositis during therapy. National Cancer Institute Monographs. 9:1990;95-98.
10. Hickey A. J., Toth B. B., Lindquist S. B. Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy. Journal of Prosthetic Dentistry. 47:1982;188-193.
11. Barrett A. P. Clinical charcteristics and mechanisms involved in chemotherapy-induced oral ulceration. Oral Surgery, Oral Medicine and Oral Pathology. 63:1987;424-428.
12. Lockhart P. B., Clark J. R. Oral complications following neoadjuvant chemotherapy in patients with head and neck cancer. National Cancer Institute Monographs. 9:1990;99-101.
13. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
14. Oken M. M., Creech R. M., Tormey D. C., et al. Toxicity and response criteria of the Eastern Co-operative Oncology Group. American Journal of Clinical Oncology. 5:1982;649-655.
15. Lockhart P. B., Sonis S. T. Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surgery, Oral Medicine and Oral Pathology. 48:1979;21-28.
16. Ferretti G. A., Raybould T. P., Brown A. T., et al. Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial. Oral Surgery, Oral Medicine and Oral Pathology. 69:1990;331-338.
17. Minsky B. D., Cohen A. M., Kemeny N., et al. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. International Journal of Radiation Oncology, Biology, Physics. 25:1993;821-827.
18. Nobile M. T., Rosso R., Sertoli M. R., et al. Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinoma. European Journal of Cancer. 28A:1992;1823-1827.
19. Rosso R., Mazzei T., Sobrero A., et al. Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma. European Journal of Cancer. 30A:1994;338-343.
20. Levi F. A., Zidani R., Vannetzel J. M., et al. Chronomodulared versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. Journal of the National Cancer Institute. 86:1994;1608-1617.
21. Ohtsu A., Yoshida S., Saito D., et al. An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer. Japanese Journal of Clinical Oncology. 21:1991;120-124.
22. Pyrhonen S., Kuitunen T., Nyandoto P., Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer. 71:1995;587-591.
23. Lacave A. J., Baron F. J., Anton L. M., et al. Combination chemotherapy with cisplatin and 5- fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial. Annals of Oncology. 2:1991;751-754.
24. Osaki T., Ueta E., Yoneda K., Hirota J., Yamamoto T. Prophylaxis of oral mucositis associated with chemotherapy for oral carcinoma by Azelatine hydrochloride (Azelastine) with other antioxidants. Head and Neck. 16:1994;331-339.
25. Merlano M., Vitale V., Rosso R., et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. New England Journal of Medicine. 327:1992;1115-1121.
26. Shirinian M. H., Weber R. S., Lippman, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the MD. Anderson Cancer Center experience. Head and Neck. 16:1994;39-44.
27. Brizel D. M., Leopold K. A., Fisher S. R., et al. A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics. 28:1994;213-220.
28. Mohapatro S. K., Daandapat M. C., Padhi N. C. Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer. Journal of the Indian Medical Association. 90:1992;39-42.
29. Lamar R. E., Greco F. A., Johnson D. H., Murphy P. B., Hainsworth J. D. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer. Cancer. 73:1994;1842-1848.
30. Mandel I. D. The functions of saliva. Journal of Dental Research. 66:(Special issue):1987;623-627.
31. Levine, R.S. Saliva: 1. The nature of saliva. Dental Update 1989; April: 102-6.
32. Wolff A., Fox P. C., Ship J. A., Atkinson J. C., Macynski A. A., Baum B. J. Oral mucosal status and major salivary gland function. Oral Surgery, Oral Medicine and Oral Pathology. 70:1990;49-54.
33. Oppenheim F. G., Xu T., McMillian F. M. Histatins, a novel family of histadine-rich proteins in human parotid secretion: isolation, characterization, primary structure and fungistatic effects on Candida albicans. Journal of Biological Chemistry. 263:1988;7472-7477.
34. Wolff A., Atkinson J. C., Macynski A. A., Fox P. C. Pretherapy interventions to modify salivary dysfunction. National Cancer Institute Monographs. 9:1990;87-90.
35. Dawes C. Physiological factors affecting salivary flow rate, Oral sugar clearance, and the sensation of dry mouth in man. Journal of Dental Research. 66:(Special issue):1987;648-653.
36. Sreebny L. M., Valdini A. Xerostomia Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surgery, Oral Medicine and Oral Pathology. 66:1988;451-458.
37. Redding S. W. Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis. National Cancer Institute Monographs. 9:1990;103-105.
38. Greenberg M. S., Friedman H., Cohen S. G., Oh S. H., Laster L., Starr S. A comparative study of herpes simplex infections in renal transplant and leukemic patients. Journal of Infectious Diseases. 156:1987;280-287.
39. McCarthy G. M., Skillings J. R. Orofacial complications of chemotherapy for breast cancer. Oral Surgery, Oral Medicine and Oral Pathology. 74:1992;172-178.
40. Armitage P., Berry G., editors. Statistical Methods in Medical Research. 2nd ed. Oxford: Blackwell, 1987.
41. Kovach, J.S. Pharmacokinetic studies of anticancer agents during phase I trials. In: Ames M.M., Powis G., Kovach J.S., editors. Pharmacokinetics of Anticancer Agents in Humans. Amsterdam: Elsevier Science Publishers, 1983. p. 451-460.
42. Sonis, S.T. Epidemiology, frequency, distribution, mechanism, and histopathology. In: Peterson D., Sonis S. (editors). Oral Complications of Cancer Chemotherapy. Boston: Martinus Nijhoff Publishers, 1983. p. 1-12.
43. Sonis, S.T. Oral complications of cancer therapy. In: DeVita Jr V.T., Hellman S., Rosenberg S.A. (editors). Cancer Principles and Practice of Oncology. 3rd Edition. Philadelphia: JB Lippincott Co, 1989. p. 2144-52.
44. Graham K. M., Pecoraro D. A., Ventura M., Meyer C. C. Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nursing. 16:1993;117-122.
45. Sonis S., Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology. 5:1991;11-18.
46. Overholser C. D., Peterson D. E., Williams L. T., Schimpff S. C. Periodontal infection in patients with acute nonlymphocytic leukemia. Archives of International Medicine. 142:1982;551-554.
47. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nursing. 2:1979;185-199.
48. Dreizen S., McCredie K. B., Keating M. J. Chemotherapy-induced oral mucositis in adult leukemia. Postgraduate Medicine. 69:1981;103-112.
49. Sonis S. T., Sonis A. L., Lieberman A. Oral complications in patients receiving treatment for malignancies other than head and neck. Journal of the American Dental Association. 97:1978;468-472.
50. Sonis S. T., Sonis A. L. Oral complications of cancer chemotherapy in paediatric patients. Journal of Pedodontics. 3:1979;122-128.
51. Lichtman S. M. Physiological aspects of aging. Implications for the treatment of cancer. Drugs Aging. 7:1995;212-225.
52. Balducci L., Mowry K. Pharmacology and organ toxicity of chemotherapy in older patients. Oncology. 6:1992;62-68.
53. NIH Consensus Development Conference Statement: oral complications of cancer chemotherapies. National Cancer Institute Monographs 1990;9:3-8.
54. Wingard J. R. Infectious and noninfectious systemic consequences. NCI Monographs. 9:1990;21-26.
55. Barrett A. P. A long-term prospective clinical study of orofacial herpes simplex virus infection in acute leukemia. Oral Surgery, Oral Medicine and Oral Pathology. 61:1986;149-152.
56. Overholser C. D., Peterson D. E., Williams L. T., et al. Periodontal infection in patients with acute nonlymphocytic leukemia: prevalence of acute exacerbations. Archives of International Medicine. 142:1987;551-554.
57. Peterson D.E. Oral complications associated with hematologic neoplasms and their treatment. In: Peterson D.E., Elias E.G., Sonis S.T., editors. Head and Neck Management of the Cancer Patients. Boston: Martinus Nijhoff, 1986. p. 351-60.
58. Whitley R.J. Herpes simplex viruses. In: Fields B.N., Knipe D.M., Chanock R.M., editors. Virology, 2nd Edition. New York: Raven Press, 1990. p. 1843-87.
59. Brightman V.J., Felix D., Goldrich-Segal S. Drug-induced xerostomia and dysgeusia. Journal of Dentistry Research 1979; 58A:326 (abstract no. 936).
60. Navazesh M., Ship I. I. Xerostomia: diagnosis and treatment. American Journal of Otolaryngology. 4:1983;283-292.
61. Kusler D. L., Rambur B. A. Treatment for radiation-induced xerostomia: an innovative remedy. Cancer Nursing. 15:1992;191-195.
62. Driezen S., Brown L. R., Handler S., Levy B. M. Radiation induced xerostomia in cancer patients effect on salivary and serum electrolytes. Cancer. 38:1976;273.
63. Lieschke G. J., Ramenghi U., O'Connor M. P., Sheridan W., Szer J., Morstyn G. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. British Journal of Haematology. 82:1992;589-595.
64. Barrett A. P. Neutropenic ulceration: a distinctive clinical entity. Journal of Periodontology. 58:1987;51-55.
65. Mattsson T., Heimdahl A., Dahllof G., Nilsson B., Lonnqvist B., Ringen O. Variables predicting oral mucosal lesions in allogenic bone marrow recipients. Head and Neck. 13:1991;224-229.
66. Katano M., Nakamura M., Matsuo T., Iyama A., Hisatsugu T. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis. Surgery Today. 25:1995;202-206.